Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Recent advances in copper radiopharmaceuticals.

Hao G, Singh AN, Oz OK, Sun X.

Curr Radiopharm. 2011 Apr;4(2):109-21. Review.

PMID:
22191650
2.

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

Shokeen M, Anderson CJ.

Acc Chem Res. 2009 Jul 21;42(7):832-41. doi: 10.1021/ar800255q.

3.

A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.

Li F, Jiang S, Zu Y, Lee DY, Li Z.

J Nucl Med. 2014 Sep;55(9):1525-31. doi: 10.2967/jnumed.114.138925. Epub 2014 Jun 26.

4.

Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.

Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K.

Cancer Sci. 2011 Jan;102(1):117-21. doi: 10.1111/j.1349-7006.2010.01763.x. Epub 2010 Nov 10.

5.

A comparison of PET imaging characteristics of various copper radioisotopes.

Williams HA, Robinson S, Julyan P, Zweit J, Hastings D.

Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1473-80. Epub 2005 Oct 29.

PMID:
16258764
6.

The development of copper radiopharmaceuticals for imaging and therapy.

Shokeen M, Wadas TJ.

Med Chem. 2011 Sep;7(5):413-29. Review.

PMID:
21711219
7.

Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.

Ruangma A, Bai B, Lewis JS, Sun X, Welch MJ, Leahy R, Laforest R.

Nucl Med Biol. 2006 Feb;33(2):217-26.

PMID:
16546676
8.

Enantiopure bifunctional chelators for copper radiopharmaceuticals--does chirality matter in radiotracer design?

Singh AN, Dakanali M, Hao G, Ramezani S, Kumar A, Sun X.

Eur J Med Chem. 2014 Jun 10;80:308-15. doi: 10.1016/j.ejmech.2014.04.071. Epub 2014 Apr 25.

PMID:
24793881
9.

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

Anderson CJ, Ferdani R.

Cancer Biother Radiopharm. 2009 Aug;24(4):379-93. doi: 10.1089/cbr.2009.0674.

10.

PET with non-standard nuclides.

Hao G, Singh AN, Liu W, Sun X.

Curr Top Med Chem. 2010;10(11):1096-112. Review.

PMID:
20388114
11.

Copper chelation chemistry and its role in copper radiopharmaceuticals.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ.

Curr Pharm Des. 2007;13(1):3-16. Review.

PMID:
17266585
12.

[PET radiopharmaceuticals: novelties and new possibilities].

Környei J, Mikecz P, Tóth G.

Magy Onkol. 2014 Dec;58(4):245-50. Epub 2014 Oct 1. Hungarian.

13.

Efficient synthesis of new tetradentate ligands with potential applications for 64Cu PET-imaging.

Bodio E, Julienne K, Gouin SG, Faivre-Chauvet A, Deniaud D.

Bioorg Med Chem Lett. 2011 Feb 1;21(3):924-7. doi: 10.1016/j.bmcl.2010.12.072. Epub 2010 Dec 19.

PMID:
21236669
14.

Copper radionuclides and radiopharmaceuticals in nuclear medicine.

Blower PJ, Lewis JS, Zweit J.

Nucl Med Biol. 1996 Nov;23(8):957-80. Review.

PMID:
9004284
15.

Decay data and production yields of some non-standard positron emitters used in PET.

Qaim SM.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):111-20. Epub 2008 Jan 5. Review.

16.

The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.

Ikotun OF, Lapi SE.

Future Med Chem. 2011 Apr;3(5):599-621. doi: 10.4155/fmc.11.14. Review.

PMID:
21526898
17.

Molecular imaging with copper-64.

Smith SV.

J Inorg Biochem. 2004 Nov;98(11):1874-901.

PMID:
15522415
18.

Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.

Hohn A, Zimmermann K, Schaub E, Hirzel W, Schubiger PA, Schibli R.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):145-50. Epub 2008 Jan 5. Review.

19.

Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.

Matarrese M, Bedeschi P, Scardaoni R, Sudati F, Savi A, Pepe A, Masiello V, Todde S, Gianolli L, Messa C, Fazio F.

Appl Radiat Isot. 2010 Jan;68(1):5-13. doi: 10.1016/j.apradiso.2009.08.010. Epub 2009 Aug 25.

PMID:
19736021
20.

Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes.

Cutler CS, Wuest M, Anderson CJ, Reichert DE, Sun Y, Martell AE, Welch MJ.

Nucl Med Biol. 2000 May;27(4):375-80.

PMID:
10938473

Supplemental Content

Support Center